Skip to main content
NCBI home page
Gut logoLink to Gut
. 1994;35(3 Suppl):S23–S27. doi: 10.1136/gut.35.3_suppl.s23

Octreotide in variceal bleeding.

A K Burroughs 1
PMCID: PMC1374392  PMID: 8206396

Abstract

Bleeding from oesophageal varices has a high death rate. Injection sclerotherapy is the most appropriate treatment but facilities for this are not always available. Balloon tamponade and vasoactive therapy may be used as stop gap measures. Somatostatin and octreotide are therapeutic candidates for the treatment of variceal bleeding and there are several trials that have compared somatostatin and octreotide with other treatments for this condition. The results of these trials are summarised and discussed. A meta analysis of the group of trials of placebo or H2 antagonists v somatostatin or octreotide showed a significant advantage of somatostatin or octreotide in terms of efficacy, but no difference in mortality. The trials discussed seem to show that somatostatin and octreotide are at least as effective as other treatments, with the benefit of fewer adverse effects, and thus represent the best vasoactive agents. Additionally, they may have a role as adjuvant treatment to emergency sclerotherapy for active bleeders and this must be further investigated.

Full text

PDF
S23

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albillos A., Colombato L. A., Lee F. Y., Groszmann R. J. Octreotide ameliorates vasodilatation and Na+ retention in portal hypertensive rats. Gastroenterology. 1993 Feb;104(2):575–579. doi: 10.1016/0016-5085(93)90429-g. [DOI] [PubMed] [Google Scholar]
  2. Avgerinos A., Klonis C., Rekoumis G., Gouma P., Papadimitriou N., Raptis S. A prospective randomized trial comparing somatostatin, balloon tamponade and the combination of both methods in the management of acute variceal haemorrhage. J Hepatol. 1991 Jul;13(1):78–83. doi: 10.1016/0168-8278(91)90867-b. [DOI] [PubMed] [Google Scholar]
  3. Bories P., Pomier-Layrargues G., Chotard J. P., Jacob C., Michel H. La somatostatine diminue l'hypertension portale chez le cirrhotique. Gastroenterol Clin Biol. 1980;4(8-9):616–617. [PubMed] [Google Scholar]
  4. Bosch J., Kravetz D., Rodes J. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin. Gastroenterology. 1981 Mar;80(3):518–525. [PubMed] [Google Scholar]
  5. Burroughs A. K., McCormick P. A., Hughes M. D., Sprengers D., D'Heygere F., McIntyre N. Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding. Gastroenterology. 1990 Nov;99(5):1388–1395. doi: 10.1016/0016-5085(90)91166-4. [DOI] [PubMed] [Google Scholar]
  6. Chojkier M., Groszmann R. J., Atterbury C. E., Bar-Meir S., Blei A. T., Frankel J., Glickman M. G., Kniaz J. L., Schade R., Taggart G. J. A controlled comparison of continuous intraarterial and intravenous infusions of vasopressin in hemorrhage from esophageal varices. Gastroenterology. 1979 Sep;77(3):540–546. [PubMed] [Google Scholar]
  7. Clanet J., Tournut R., Fourtanier G., Joncquiert F., Pascal J. P. Traitement par la pitressine des hémorragies par rupture de varices oesophagiennes chez le cirrhotique. Etude contrôlée. Acta Gastroenterol Belg. 1978 Sep-Oct;41(9-10):539–543. [PubMed] [Google Scholar]
  8. Conn H. O., Ramsby G. R., Storer E. H., Mutchnick M. G., Joshi P. H., Phillips M. M., Cohen G. A., Fields G. N., Petroski D. Intraarterial vasopressin in the treatment of upper gastrointestinal hemorrhage: a prospective, controlled clinical trial. Gastroenterology. 1975 Feb;68(2):211–221. [PubMed] [Google Scholar]
  9. Dudley F. J. Somatostatin and portal hypertensive bleeding: a safe therapeutic alternative? Gastroenterology. 1992 Dec;103(6):1973–1977. doi: 10.1016/0016-5085(92)91459-h. [DOI] [PubMed] [Google Scholar]
  10. Eriksson L. S., Brundin T., Söderlund C., Wahren J. Haemodynamic effects of a long-acting somatostatin analogue in patients with liver cirrhosis. Scand J Gastroenterol. 1987 Oct;22(8):919–925. doi: 10.3109/00365528708991936. [DOI] [PubMed] [Google Scholar]
  11. Eriksson L. S., Law D. H., Sato Y., Wahren J. Influence of somatostatin on splanchnic haemodynamics in patients with liver cirrhosis. Clin Physiol. 1984 Feb;4(1):5–11. doi: 10.1111/j.1475-097x.1984.tb00639.x. [DOI] [PubMed] [Google Scholar]
  12. Fogel M. R., Knauer C. M., Andres L. L., Mahal A. S., Stein D. E., Kemeny M. J., Rinki M. M., Walker J. E., Siegmund D., Gregory P. B. Continuous intravenous vasopressin in active upper gastrointestinal bleeding. Ann Intern Med. 1982 May;96(5):565–569. doi: 10.7326/0003-4819-96-5-565. [DOI] [PubMed] [Google Scholar]
  13. Freeman J. G., Cobden I., Record C. O. Placebo-controlled trial of terlipressin (glypressin) in the management of acute variceal bleeding. J Clin Gastroenterol. 1989 Feb;11(1):58–60. doi: 10.1097/00004836-198902000-00014. [DOI] [PubMed] [Google Scholar]
  14. Gimson A. E., Westaby D., Hegarty J., Watson A., Williams R. A randomized trial of vasopressin and vasopressin plus nitroglycerin in the control of acute variceal hemorrhage. Hepatology. 1986 May-Jun;6(3):410–413. doi: 10.1002/hep.1840060314. [DOI] [PubMed] [Google Scholar]
  15. Ginès A., Salmerón J. M., Ginès P., Jiménez W., Saló J., Piera C., Clària J., Rivera F., Arroyo V., Rodés J. Effects of somatostatin on renal function in cirrhosis. Gastroenterology. 1992 Dec;103(6):1868–1874. doi: 10.1016/0016-5085(92)91446-b. [DOI] [PubMed] [Google Scholar]
  16. Graham D. Y., Smith J. L. The course of patients after variceal hemorrhage. Gastroenterology. 1981 Apr;80(4):800–809. [PubMed] [Google Scholar]
  17. Groszmann R. J., Bosch J., Grace N. D., Conn H. O., Garcia-Tsao G., Navasa M., Alberts J., Rodes J., Fischer R., Bermann M. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology. 1990 Nov;99(5):1401–1407. doi: 10.1016/0016-5085(90)91168-6. [DOI] [PubMed] [Google Scholar]
  18. Hwang S. J., Lin H. C., Chang C. F., Lee F. Y., Lu C. W., Hsia H. C., Wang S. S., Lee S. D., Tsai Y. T., Lo K. J. A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal bleeding. J Hepatol. 1992 Nov;16(3):320–325. doi: 10.1016/s0168-8278(05)80663-4. [DOI] [PubMed] [Google Scholar]
  19. Jaramillo J. L., de la Mata M., Miño G., Costán G., Gómez-Camacho F. Somatostatin versus Sengstaken balloon tamponade for primary haemostasia of bleeding esophageal varices. A randomized pilot study. J Hepatol. 1991 Jan;12(1):100–105. doi: 10.1016/0168-8278(91)90917-z. [DOI] [PubMed] [Google Scholar]
  20. Jenkins S. A., Baxter J. N., Corbett W. A., Shields R. Effects of a somatostatin analogue SMS 201-995 on hepatic haemodynamics in the pig and on intravariceal pressure in man. Br J Surg. 1985 Dec;72(12):1009–1012. doi: 10.1002/bjs.1800721225. [DOI] [PubMed] [Google Scholar]
  21. Jenkins S. A., Baxter J. N., Corbett W. A., Shields R. The effects of a somatostatin analogue SMS 201-995 on hepatic haemodynamics in the cirrhotic rat. Br J Surg. 1985 Nov;72(11):864–867. doi: 10.1002/bjs.1800721105. [DOI] [PubMed] [Google Scholar]
  22. Jenkins S. A., Baxter J. N., Corbett W., Devitt P., Ware J., Shields R. A prospective randomised controlled clinical trial comparing somatostatin and vasopressin in controlling acute variceal haemorrhage. Br Med J (Clin Res Ed) 1985 Jan 26;290(6464):275–278. doi: 10.1136/bmj.290.6464.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Johnson W. C., Widrich W. C., Ansell J. E., Robbins A. H., Nabseth D. C. Control of bleeding varices by vasopressin: a prospective randomized study. Ann Surg. 1977 Sep;186(3):369–376. doi: 10.1097/00000658-197709000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kleber G., Sauerbruch T., Fischer G., Paumgartner G. Somatostatin does not reduce oesophageal variceal pressure in liver cirrhotics. Gut. 1988 Feb;29(2):153–156. doi: 10.1136/gut.29.2.153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kravetz D., Bosch J., Terés J., Bruix J., Rimola A., Rodés J. Comparison of intravenous somatostatin and vasopressin infusions in treatment of acute variceal hemorrhage. Hepatology. 1984 May-Jun;4(3):442–446. doi: 10.1002/hep.1840040315. [DOI] [PubMed] [Google Scholar]
  26. MERIGAN T. C., Jr, PLOTKIN G. R., DAVIDSON C. S. Effect of intravenously administered posterior pituitary extract on hemorrhage from bleeding esophageal varices. A controlled evaluation. N Engl J Med. 1962 Jan 18;266:134–135. doi: 10.1056/NEJM196201182660307. [DOI] [PubMed] [Google Scholar]
  27. Mallory A., Schaefer J. W., Cohen J. R., Holt S. A., Norton L. W. Selective intra-arterial vasopression in fusion for upper gastrointestinal tract hemorrhage: a controlled trial. Arch Surg. 1980 Jan;115(1):30–32. doi: 10.1001/archsurg.1980.01380010022004. [DOI] [PubMed] [Google Scholar]
  28. McKee R. A study of octreotide in oesophageal varices. Digestion. 1990;45 (Suppl 1):60–65. doi: 10.1159/000200264. [DOI] [PubMed] [Google Scholar]
  29. Merkel C., Gatta A., Zuin R., Finucci G. F., Nosadini R., Ruol A. Effect of somatostatin on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension. Digestion. 1985;32(2):92–98. doi: 10.1159/000199224. [DOI] [PubMed] [Google Scholar]
  30. Mountokalakis T., Kallivretakis N., Mayopoulou-Symvoulidou D., Karvountzis G., Tolis G. Enhancement of renal function by a long-acting somatostatin analogue in patients with decompensated cirrhosis. Nephrol Dial Transplant. 1988;3(5):604–607. doi: 10.1093/oxfordjournals.ndt.a091713. [DOI] [PubMed] [Google Scholar]
  32. Pinto Correia J., Martins Alves M., Alexandrino P., Silveira J. Controlled trial of vasopressin and balloon tamponade in bleeding esophageal varices. Hepatology. 1984 Sep-Oct;4(5):885–888. doi: 10.1002/hep.1840040515. [DOI] [PubMed] [Google Scholar]
  33. Pringle S. D., McKee R. F., Garden O. J., Lorimer A. R., Carter D. C. The effect of a long-acting somatostatin analogue on portal and systemic haemodynamics in cirrhosis. Aliment Pharmacol Ther. 1988 Oct;2(5):451–459. doi: 10.1111/j.1365-2036.1988.tb00718.x. [DOI] [PubMed] [Google Scholar]
  34. Ready J. B., Robertson A. D., Goff J. S., Rector W. G., Jr Assessment of the risk of bleeding from esophageal varices by continuous monitoring of portal pressure. Gastroenterology. 1991 May;100(5 Pt 1):1403–1410. [PubMed] [Google Scholar]
  35. Saari A., Klvilaakso E., Inberg M., Päkkönen M., Lahtinen J., Höckerstedt K., Schröder T. Comparison of somatostatin and vasopressin in bleeding esophageal varices. Am J Gastroenterol. 1990 Jul;85(7):804–807. [PubMed] [Google Scholar]
  36. Shields R., Jenkins S. A., Baxter J. N., Kingsnorth A. N., Ellenbogen S., Makin C. A., Gilmore I., Morris A. I., Ashby D., West C. R. A prospective randomised controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding oesophageal varices. J Hepatol. 1992 Sep;16(1-2):128–137. doi: 10.1016/s0168-8278(05)80105-9. [DOI] [PubMed] [Google Scholar]
  37. Sonnenberg A., West C. Somatostatin reduces gastric mucosal blood flow in normal subjects but not in patients with cirrhosis of the liver. Gut. 1983 Feb;24(2):148–153. doi: 10.1136/gut.24.2.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Sonnenberg G. E., Keller U., Perruchoud A., Burckhardt D., Gyr K. Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects. Gastroenterology. 1981 Mar;80(3):526–532. [PubMed] [Google Scholar]
  39. Sung J. J., Chung S. C., Lai C. W., Chan F. K., Leung J. W., Yung M. Y., Kassianides C., Li A. K. Octreotide infusion or emergency sclerotherapy for variceal haemorrhage. Lancet. 1993 Sep 11;342(8872):637–641. doi: 10.1016/0140-6736(93)91758-e. [DOI] [PubMed] [Google Scholar]
  40. Söderlund C., Magnusson I., Törngren S., Lundell L. Terlipressin (triglycyl-lysine vasopressin) controls acute bleeding oesophageal varices. A double-blind, randomized, placebo-controlled trial. Scand J Gastroenterol. 1990 Jun;25(6):622–630. doi: 10.3109/00365529009095539. [DOI] [PubMed] [Google Scholar]
  41. Tsai Y. T., Lay C. S., Lai K. H., Ng W. W., Yeh Y. S., Wang J. Y., Chiang T. T., Lee S. D., Chiang B. N., Lo K. J. Controlled trial of vasopressin plus nitroglycerin vs. vasopressin alone in the treatment of bleeding esophageal varices. Hepatology. 1986 May-Jun;6(3):406–409. doi: 10.1002/hep.1840060313. [DOI] [PubMed] [Google Scholar]
  42. Tydén G., Samnegård H., Thulin L., Muhrbeck O., Efendić S. Circulatory effects of somatostatin in anesthetized man. Acta Chir Scand. 1979;145(7):443–446. [PubMed] [Google Scholar]
  43. Valenzuela J. E., Schubert T., Fogel M. R., Strong R. M., Levine J., Mills P. R., Fabry T. L., Taylor L. W., Conn H. O., Posillico J. T. A multicenter, randomized, double-blind trial of somatostatin in the management of acute hemorrhage from esophageal varices. Hepatology. 1989 Dec;10(6):958–961. doi: 10.1002/hep.1840100611. [DOI] [PubMed] [Google Scholar]
  44. Vlavianos P., Gimson A. E., Westaby D., Williams R. Balloon tamponade in variceal bleeding: use and misuse. BMJ. 1989 Apr 29;298(6681):1158–1158. doi: 10.1136/bmj.298.6681.1158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Wahren J. Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus. Lancet. 1976 Dec 4;2(7997):1213–1216. doi: 10.1016/s0140-6736(76)91142-9. [DOI] [PubMed] [Google Scholar]
  46. Walker S., Kreichgauer H. P., Bode J. C. Terlipressin vs. somatostatin in bleeding esophageal varices: a controlled, double-blind study. Hepatology. 1992 Jun;15(6):1023–1030. doi: 10.1002/hep.1840150609. [DOI] [PubMed] [Google Scholar]
  47. Walker S., Stiehl A., Raedsch R., Kommerell B. Terlipressin in bleeding esophageal varices: a placebo-controlled, double-blind study. Hepatology. 1986 Jan-Feb;6(1):112–115. doi: 10.1002/hep.1840060121. [DOI] [PubMed] [Google Scholar]
  48. Westaby D. Emergency and elective endoscopic therapy for variceal haemorrhage. Baillieres Clin Gastroenterol. 1992 Sep;6(3):465–480. doi: 10.1016/0950-3528(92)90033-b. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES